Published in AIDS Weekly, August 22nd, 2005
Results showed that plasma levels of all 4 drugs remained within previously described pharmacokinetic parameters, supporting the potential for this combination to be a useful once-daily regimen for the treatment of HIV infection. However, further study is necessary to determine conclusively the safety and efficacy of Lexiva/ritonavir in combination with Truvada.
The study, which was supported by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.